Profound Medical (PROF) Net Cash Flow (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124.62% |
| Dec 31, 2025 | 462.62% |
| Sep 30, 2025 | 30.05% |
| Jun 30, 2025 | -60.32% |
| Mar 31, 2025 | -129.01% |
| Dec 31, 2024 | 498.44% |
| Sep 30, 2024 | -8.74% |
| Jun 30, 2024 | -142.83% |
| Mar 31, 2024 | 311.57% |
| Dec 31, 2023 | -66.29% |
| Sep 30, 2023 | 73.00% |
| Jun 30, 2023 | -310.43% |
| Mar 31, 2023 | 120.98% |
| Dec 31, 2022 | -749.79% |
| Sep 30, 2022 | -72.56% |
| Jun 30, 2022 | 368.40% |
| Mar 31, 2022 | 80.11% |
| Dec 31, 2021 | -217.46% |
| Sep 30, 2021 | 750.57% |
| Jun 30, 2021 | -171.58% |
| Sep 30, 2020 | 1,435.21% |
| Jun 30, 2020 | -110.67% |
| Mar 31, 2020 | 100.82% |
| Dec 31, 2019 | 176.50% |
| Sep 30, 2019 | 207.99% |
| Jun 30, 2019 | -79.09% |
| Mar 31, 2019 | 88.85% |